These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 12620172)

  • 21. Early administration of intravenous magnesium to high-risk patients with acute myocardial infarction in the Magnesium in Coronaries (MAGIC) Trial: a randomised controlled trial.
    Magnesium in Coronaries (MAGIC) Trial Investigators
    Lancet; 2002 Oct; 360(9341):1189-96. PubMed ID: 12401244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute myocardial infarction without thrombolytic therapy: beneficial effects of magnesium sulfate.
    Shechter M; Hod H; Chouraqui P; Kaplinsky E; Rabinowitz B
    Herz; 1997 Jun; 22 Suppl 1():73-6. PubMed ID: 9259191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Magnesium in myocardial infarct].
    Lüderitz B
    Dtsch Med Wochenschr; 1994 Aug; 119(31-32):1102-3. PubMed ID: 8055754
    [No Abstract]   [Full Text] [Related]  

  • 24. Protective effect of intravenous magnesium in acute myocardial infarction following thrombolytic therapy.
    Raghu C; Peddeswara Rao P; Seshagiri Rao D
    Int J Cardiol; 1999 Dec; 71(3):209-15. PubMed ID: 10636525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reappraisal of beta-blocker therapy in the acute and chronic post-myocardial infarction period.
    Borrello F; Beahan M; Klein L; Gheorghiade M
    Rev Cardiovasc Med; 2003; 4 Suppl 3():S13-24. PubMed ID: 14564230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of fondaparinux as an adjunct to thrombolytic therapy in acute myocardial infarction: a subgroup analysis of the OASIS-6 trial.
    Peters RJ; Joyner C; Bassand JP; Afzal R; Chrolavicius S; Mehta SR; Oldgren J; Wallentin L; Budaj A; Fox KA; Yusuf S;
    Eur Heart J; 2008 Feb; 29(3):324-31. PubMed ID: 18245119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnesium and myocardial infarction.
    Casscells W
    Lancet; 1994 Apr; 343(8901):807-9. PubMed ID: 7908073
    [No Abstract]   [Full Text] [Related]  

  • 28. Temporal trends on the risk of arrhythmic vs. non-arrhythmic deaths in high-risk patients after myocardial infarction: a combined analysis from multicentre trials.
    Yap YG; Duong T; Bland M; Malik M; Torp-Pedersen C; Køber L; Connolly SJ; Marchant B; Camm J
    Eur Heart J; 2005 Jul; 26(14):1385-93. PubMed ID: 15914501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term outcome after intravenous magnesium sulphate in suspected acute myocardial infarction: the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2).
    Woods KL; Fletcher S
    Lancet; 1994 Apr; 343(8901):816-9. PubMed ID: 7908076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of acute beta-blocker therapy for patients with non-ST-segment elevation myocardial infarction.
    Miller CD; Roe MT; Mulgund J; Hoekstra JW; Santos R; Pollack CV; Ohman EM; Gibler WB; Peterson ED
    Am J Med; 2007 Aug; 120(8):685-92. PubMed ID: 17679127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Magnesium and myocardial infarction.
    Shechter M; Shechter A
    Clin Calcium; 2005 Nov; 15(11):111-5. PubMed ID: 16272621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trial.
    Sabatine MS; Morrow DA; Giugliano RP; Murphy SA; Demopoulos LA; DiBattiste PM; Weintraub WS; McCabe CH; Antman EM; Cannon CP; Braunwald E
    Circulation; 2004 Feb; 109(7):874-80. PubMed ID: 14757697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term follow-up after acute myocardial infarction in patients randomized to treatment with intravenous magnesium or intravenous propranolol in the acute phase.
    Abraham AS; Balkin J; Rosenmann D; Ilan M; Klutstein M; Zion MM
    Magnes Res; 1994 Dec; 7(3-4):273-6. PubMed ID: 7786690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Post-reperfusion myocardial infarction: long-term survival improvement using adenosine regulation with acadesine.
    Mangano DT; Miao Y; Tudor IC; Dietzel C; ;
    J Am Coll Cardiol; 2006 Jul; 48(1):206-14. PubMed ID: 16814669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial.
    Aguilar D; Solomon SD; Køber L; Rouleau JL; Skali H; McMurray JJ; Francis GS; Henis M; O'Connor CM; Diaz R; Belenkov YN; Varshavsky S; Leimberger JD; Velazquez EJ; Califf RM; Pfeffer MA
    Circulation; 2004 Sep; 110(12):1572-8. PubMed ID: 15364810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2).
    Woods KL; Fletcher S; Roffe C; Haider Y
    Lancet; 1992 Jun; 339(8809):1553-8. PubMed ID: 1351547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Magnesium in acute myocardial infarction: overview of available evidence.
    Antman EM
    Am Heart J; 1996 Aug; 132(2 Pt 2 Su):487-95; discussion 496-502. PubMed ID: 8694009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Geographic variation in the treatment of acute myocardial infarction in the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial.
    Reed SD; McMurray JJ; Velazquez EJ; Schulman KA; Califf RM; Kober L; Maggioni AP; Van de Werf F; White HD; Diaz R; Mareev V; Murin J;
    Am Heart J; 2006 Sep; 152(3):500-8. PubMed ID: 16923421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized prospective placebo-controlled study of intravenous magnesium sulphate vs. metoclopramide in the management of acute migraine attacks in the Emergency Department.
    Cete Y; Dora B; Ertan C; Ozdemir C; Oktay C
    Cephalalgia; 2005 Mar; 25(3):199-204. PubMed ID: 15689195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.